Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA-132 (miR-132) is a highly conserved, short non-coding RNA molecule that plays a critical regulatory role in gene expression, primarily by binding to target mRNAs and inhibiting their translation or promoting their degradation. It is involved in various biological processes including neuronal development, synaptic transmission, inflammation, and angiogenesis. Dysregulation of miR-132 is implicated in Alzheimer's disease and other neurological disorders.
Binds to complementary sequences in target mRNAs, leading to translational repression or mRNA degradation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA-132 (miR-132).